1985
DOI: 10.1016/0014-2999(85)90151-7
|View full text |Cite
|
Sign up to set email alerts
|

[3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
22
1

Year Published

1987
1987
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 98 publications
(25 citation statements)
references
References 7 publications
2
22
1
Order By: Relevance
“…Consistent with the latter is our previous finding that the behavioral response to signal attenuation is increased following termination of repeated administration of SCH 23390 . Since chronic treatment with SCH 23390 leads to an increase in the density of D 1 receptors in the striatum (Creese and Chen, 1985;Giorgi et al, 1993;Hess et al, 1986Hess et al, , 1988Lappalainen et al, 1992;Memo et al, 1987;O'Boyle et al, 1993;Porceddu et al, 1985), the signaling of a phasic DA decrease is expected to be amplified by the larger number of D 1 receptors, leading to an abnormally high level of compulsive lever-pressing.…”
Section: Kg Haloperidol In Regular Extinctionmentioning
confidence: 99%
See 1 more Smart Citation
“…Consistent with the latter is our previous finding that the behavioral response to signal attenuation is increased following termination of repeated administration of SCH 23390 . Since chronic treatment with SCH 23390 leads to an increase in the density of D 1 receptors in the striatum (Creese and Chen, 1985;Giorgi et al, 1993;Hess et al, 1986Hess et al, , 1988Lappalainen et al, 1992;Memo et al, 1987;O'Boyle et al, 1993;Porceddu et al, 1985), the signaling of a phasic DA decrease is expected to be amplified by the larger number of D 1 receptors, leading to an abnormally high level of compulsive lever-pressing.…”
Section: Kg Haloperidol In Regular Extinctionmentioning
confidence: 99%
“…Thus, compounds that abolish phasic DA responses or their detection (eg D 1 agonists) may attenuate compulsions. A potential advantage of treatment with D 1 agonists rather than antagonists is that chronic administration of antagonists (but not agonists) may result in exaggeration of symptoms following treatment termination, as a result of treatment-induced increase in the density of D 1 receptors (Creese and Chen, 1985;Giorgi et al, 1993;Hess et al, 1986Hess et al, , 1988Lappalainen et al, 1992;Memo et al, 1987;O'Boyle et al, 1993;Porceddu et al, 1985). Indeed, repeated administration of SCH 23390 in rats led to an increase in compulsive behavior following the termination of drug administration .…”
Section: Kg Haloperidol In Regular Extinctionmentioning
confidence: 99%
“…These findings are consistent with the results reported here, indicating that a 94% increase of D 1 receptor density was associated with the administration of the selective antagonist SCH23390. It is interesting to note that both acute (Gupta and Mishra, 1993) and chronic administration (Creese and Chen, 1985;Dawson et al, 1986;Porceddu et al, 1985) of dopamine agonists or antagonists has also been associated with significant alterations in D 1 receptor density, without any appreciable change in receptor affinity. It is possible that alterations of receptor number may be the primary mechanism through which neurons adapt to blockade of D 1 receptors.…”
Section: Discussionmentioning
confidence: 98%
“…APDs usually require two or more weeks to achieve their full effects and, for this reason, subchronic or chronic drug administration over a period of weeks to months is generally employed to model their effects on dopamine receptor subtypes (Creese and Chen, 1985;Dawson et al, 1986;Giorgi et al, 1993;Lappalainen et al, 1992;Porceddu et al, 1985;See et al, 1990). Prior studies in which low-resolution autoradiography was employed demonstrated that chronic administration of either a D 1 or D 2 antagonist increases the B max , but does not alter the K d , for each of these receptor subtypes (Creese and Chen, 1985;Dawson et al, 1986;Mc-Gonigle et al, 1989;Parashos et al, 1987;Porceddu et al, 1985). It is important to emphasize, however, that changes in receptor populations occurring as a result of prolonged APD administration are likely to involve secondary and perhaps even tertiary downstream changes in complex neural circuits.…”
Section: Introductionmentioning
confidence: 99%
“…Researchers subsequently determined that it was a compensatory reaction to the medications. 21,22,23,24,25,26,27 The drug, they said, caused an "upregulation" of the receptors.…”
Section: A Paradox Explainedmentioning
confidence: 99%